About Me
Dr. Rajsrinivas Parthasarathy: Leading Expert in Stroke Neurology and Neurointerventional Surgery
Dr. Rajsrinivas Parthasarathy is a highly accomplished and multifaceted neurologist, renowned for his expertise in stroke neurology and neuro interventional surgery. With a diverse range of qualifications, including MRCP, CCT (UK) in Neurology, and Fellowships in Vascular Neurology & Neurointerventional Surgery, he brings a wealth of knowledge and experience to the field.
After graduating from Coimbatore Medical College, Tamil Nadu, India, Dr. Parthasarathy embarked on an extensive postgraduate training journey. He underwent rigorous training in Neurology at the prestigious Royal College of Physicians, UK, and completed a Fellowship in Vascular Neurology at the Royal College of Physicians, Canada. Additionally, he pursued advanced training in Interventional Neuroradiology at Medanta, further enhancing his skills.
Notably, Dr. Parthasarathy is one of the few neurologists globally to receive specialized training in both Stroke Neurology and Neurointerventional Surgery. His fellowship training in cerebrovascular diseases was conducted at the esteemed University of Alberta, Canada, while his Interventional Neuroradiology training took place at the renowned Medanta Institute in India. This unique combination of expertise sets him apart as a leader in his field.
Certified by the Royal College of Physicians, UK, Dr. Parthasarathy has trained at prestigious institutes within the Yorkshire deanery, further solidifying his credentials. As a dedicated researcher, he has contributed to high-impact factor journals and co-edited the book “100 Interesting Cases in Neurointervention: Tips and Tricks” published by Springer, showcasing his commitment to advancing medical knowledge.
With his comprehensive training, extensive experience, and dedication to research, Dr. Rajsrinivas Parthasarathy is a trusted name in the field of stroke neurology and neurointerventional surgery, providing exceptional care and cutting-edge treatment options to patients.